ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors

NCT06332170 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

610

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: HS-20093
DRUG: Adebrelimab
DRUG: Cisplatin/ Carboplatin
DRUG: Cetuximab
DRUG: Enzalutamide

Sponsor

Hansoh BioMedical R&D Company